Leclercq J F, Bizot J, Attuel P, Coumel P
Department of Cardiology, Lariboisière University Hospital, Paris, France.
Am J Cardiol. 1997 Sep 1;80(5):645-8. doi: 10.1016/s0002-9149(97)00442-6.
Results of direct-current cardioversion of 48 patients with atrial arrhythmia taking oral flecainide were compared with those of 96 control-matched patients. After completion of 3 shocks, 98% of flecainide patients were converted versus 78% of control patients (p <0.01). Thus, despite an experimental increase in defibrillation threshold, flecainide given before cardioversion seems to have a beneficial effect.
对48例服用口服氟卡尼的房性心律失常患者进行直流电复律的结果,与96例匹配的对照患者的结果进行了比较。在3次电击完成后,98%的氟卡尼患者实现了复律,而对照患者为78%(p<0.01)。因此,尽管实验性地提高了除颤阈值,但在复律前给予氟卡尼似乎具有有益效果。